Director, Portfolio Sales

United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Healthcare, Life Science, Clinical TrialsIndustries

Requirements

Candidates should possess a degree level or equivalent experience, with 3-5+ years in sales, business development, or a similar role within the pharmaceutical, health, life science, or other regulated industries. Experience selling capital equipment, services, pharmaceutical and biotech products, or technology is required, along with a proven ability to manage long sales cycles, multi-party scenarios, and cold calling. Familiarity with the pharmaceutical industry, strong communication skills, proficiency in Microsoft Office and Salesforce.com, and a competitive, team-oriented nature are essential.

Responsibilities

The Director, Portfolio Sales will be responsible for meeting and exceeding sales targets, generating new business leads, and managing the sales process. They will manage strategic and key account relationships, close sales opportunities across Clario's business units (cardiac safety, ePRO/eCOA, and Respiratory Services), and build business relationships within assigned accounts. This role involves leading business development, preparing information for internal departments, leveraging internal resources, and managing all sales activities and administrative deliverables, including sales reports and expense reports, within Salesforce.com.

Skills

Sales

Business Development

Account Management

Salesforce.com

Clinical Trial Endpoint Technology

Cardiac Safety

ePRO/eCOA

Respiratory Services

Sales Reporting

Expense Reporting

Account Planning

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free